标题/作者	年份
Neurofilaments as biomarkers in neurological disorders M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ... Nature Reviews Neurology 14 (10), 577-589	2018
Alzheimer's disease P Scheltens, B De Strooper, M Kivipelto, H Holstege, G Chételat, ... The Lancet 397 (10284), 1577-1590	2021
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283	2019
Neurofilament light chain as a biomarker in neurological disorders L Gaetani, K Blennow, P Calabresi, M Di Filippo, L Parnetti, H Zetterberg Journal of Neurology, Neurosurgery & Psychiatry 90 (8), 870-881	2019
Pathogenic mechanisms associated with different clinical courses of multiple sclerosis H Lassmann Frontiers in immunology 9, 3116	2019
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response J Kuhle, H Kropshofer, DA Haering, U Kundu, R Meinert, C Barro, ... Neurology 92 (10), e1007-e1015	2019
Serum neurofilament light levels in normal aging and their association with morphologic brain changes M Khalil, L Pirpamer, E Hofer, MM Voortman, C Barro, D Leppert, ... Nature communications 11 (1), 812	2020
Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials L Kappos, JS Wolinsky, G Giovannoni, DL Arnold, Q Wang, C Bernasconi, ... JAMA neurology 77 (9), 1132-1140	2020
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis D Rotstein, X Montalban Nature Reviews Neurology 15 (5), 287-300	2019
Molecular biomarkers in multiple sclerosis T Ziemssen, K Akgün, W Brück Journal of neuroinflammation 16 (1), 272	2019
Neurofilaments: neurobiological foundations for biomarker applications AR Gafson, NR Barthélemy, P Bomont, RO Carare, HD Durham, JP Julien, ... Brain 143 (7), 1975-1998	2020
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257	2022
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD M Watanabe, Y Nakamura, Z Michalak, N Isobe, C Barro, D Leppert, ... Neurology 93 (13), e1299-e1311	2019
Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years E Cantó, C Barro, C Zhao, SJ Caillier, Z Michalak, R Bove, D Tomic, ... JAMA neurology 76 (11), 1359-1366	2019
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders O Ciccarelli, JA Cohen, SC Reingold, BG Weinshenker, MP Amato, ... The Lancet Neurology 18 (2), 185-197	2019
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis I Håkansson, A Tisell, P Cassel, K Blennow, H Zetterberg, P Lundberg, ... Journal of neuroinflammation 15 (1), 1-10	2018
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis D Ontaneda, E Tallantyre, T Kalincik, SM Planchon, N Evangelou The Lancet Neurology 18 (10), 973-980	2019
Blood neurofilament light: a critical review of its application to neurologic disease C Barro, T Chitnis, HL Weiner Annals of clinical and translational neurology 7 (12), 2508-2523	2020
Serum neurofilament light as a biomarker in progressive multiple sclerosis R Kapoor, KE Smith, M Allegretta, DL Arnold, W Carroll, M Comabella, ... Neurology 95 (10), 436-444	2020
A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition H Inojosa, U Proschmann, K Akgün, T Ziemssen Journal of neurology 268, 1210-1221	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。